Cancer Singapore | National University Cancer Institute, Singapore (NCIS) > Patient and Visitors > Find a Doctor > Associate Professor Dan Yock Young

Associate Professor Dan Yock Young

Senior Consultant, Division of Gastroenterology and Hepatology, National University Hospital 

Head & Associate Professor, Department of Medicine, National University of Singapore

Chair, University Medicine Cluster, National University Hospital 

Adjunct Associate Professor, Cancer Science Institute of Singapore, National University of Singapore

Associate Faculty, GIS Partnership Programme, Genome Institute of Singapore


Associate Professor Dan Yock Young obtained his MBBS from NUS in 1994 and completed his internal medicine residency, MRCP (UK) and MMed (Int Med) in 2000, before being admitted as Fellow to Academy of Medicine Singapore (Gastro) in 2004. He currently works as clinician–scientist in the National University of Singapore.


Education and Fellowships

MBBS (S'pore), PhD, MMed (Int Med), MRCP (UK), FAMS


Specialty Interests

  • Liver stem cells
  • Liver regeneration
  • Fatty liver


Awards and Honours

  • NMRC CSI Clinician Scientist Award (Junior Category) in 2006
  • NHG ASC Best Doctor Award (Gold) in 2009
  • NHG ASC Best Oral (Health Outcomes and Research) Excellent Service Awards (Silver) in 2009
  • NMRC Clinician Scientist Award in 2009



  1. Lim LG, Tan XX, Woo SJ, Dan YY, Lee YM, Lai V, Lim SG Risk factors for mortality in cirrhotic patients with sepsis. Hepatol Int. 2011 Feb 13.PMID: 21484126
  2. Riehle KJ, Dan YY, Campbell JS, Fausto N.New concepts in liver regeneration. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:203-12. doi: 10.1111/j.1440-1746.2010.06539.x. PMID: 21199532
  3. Lim LG, Aung MO, Seet BL, Tan C, Dan YY, Lee YM, Sutedja DS, Fernandes M, Lee GH, Koay E, Lim SG. Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistance. World J Gastroenterol. 2010 Oct 7;16(37):4691-6.
  4. Dan YY, Tambyah PA, Sim J, Lim J, Hsu LY, Chow WL, Fisher DA, Wong YS, Ho KY. Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat. Emerg Infect Dis. 2009 Dec;15(12):1909-16. PubMed PMID: 19961669.
  5. Teoh N, Pyakurel P, Dan YY, Swisshelm K, Hou J, Mitchell C, Fausto N, Gu Y, Farrell G. Induction of p53 Renders ATM-Deficient Mice Refractory to Hepatocarcinogenesis. Gastroenterology. 2010 Mar;138(3):1155-1165.e2. Epub 2009 Nov 14. PubMed PMID: 19919837.
  6. Dan YY. Bioengineering the artificial liver with non-hepatic cells: where are we headed? J Gastroenterol Hepatol. 2009 Feb;24(2):171-3. PubMed PMID: 19215326.
  7. Dan YY, Aung MO, Lim SG. The economics of treating chronic hepatitis B in Asia. Hepatol Int. 2008 Sep;2(3):284-95. Epub 2008 May 1. PubMed PMID: 19669256; PubMed Central PMCID: PMC2716880.
  8. Lee YM, Sutedja DS, Wai CT, Dan YY, Aung MO, Zhou L, Cheng CL, Wee A, Lim SG. A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH). Hepatol Int. 2008 Jun;2(2):196-201. Epub 2008 Feb 28. PubMed PMID: 19669304; PubMed Central PMCID: PMC2716847.
  9. Teoh NC, Dan YY, Swisshelm K, Lehman S, Wright JH, Haque J, Gu Y, Fausto N. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice. Hepatology. 2008 Jun;47(6):2078-88. PubMed PMID: 18506893.
  10. Dan YY, Yeoh GC. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol. 2008 May;23(5):687-98. Review. PubMed PMID: 18410603.


Updated as of 23 May 2016